US Patent 6995169 Analgesic compositions containing buprenorphine
Patent 6995169 was granted and assigned to Reckitt Benckiser on February, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Nov, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+633 characters)
Article
Patent abstract
An analgesic composition in parenteral unit dosage form or in a unit dosage form suitable for delivery via the mucosa comprising an amount of buprenorphine which is less than the clinical dose required to achieve pain relief and an amount of naloxone such that the ratio by weight of buprenorphine to naloxone is in the range of from 12.5:1 to 27.5:1, or an amount of naltrexone or nalmefene such that the ratio by weight of buprenorphine to naltrexone or nalmefene is in the range of from 12.5:1 to 22.5:1. The analgesic action of the buprenorphine is potentiated by the low dose of naloxone, naltrexone or nalmefene.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christopher Bourne Chapleo0
Keith McCormack0
Nicolas Calvert Varey0
Date of Patent
February 7, 2006
0Patent Application Number
101452840
Date Filed
May 14, 2002
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6995169 Analgesic compositions containing buprenorphine
Find more entities like US Patent 6995169 Analgesic compositions containing buprenorphine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.